Life Sciences

Morgan Lewis has purposefully developed our capabilities to serve the complete life sciences product life cycle and all aspects of the healthcare and life sciences industry. We understand and work creatively to solve the business, transactional, regulatory, intellectual property (IP), litigation, and related issues that our clients face along the product life cycle, from innovation protection and emerging business issues, through regulatory development and approval, to reimbursement, marketing, and distribution. Our lawyers handle litigation in all relevant areas (including fraud and abuse, product liability and IP), labor, employment, and benefits, and antitrust, and work closely with clients on mergers and acquisitions, collaborations and licensing agreements, and outsourcing.

The diversity of our life sciences industry clients gives us a unique and comprehensive insight into the business and legal challenges facing all aspects of the sector, including large, midsize, and emerging biopharma companies, medical devices, food and agriculture, consumer healthcare products companies, and healthcare providers. We represent companies that operate in the life sciences sector as well as entities that invest in it, such as venture capital and private equity funds focused on the industry. As a full-service firm with offices in the financial and regulatory centers of critical importance to the industry globally, we are uniquely situated to provide assistance over the complete range of industry activities.